South Dakota · Senate

reschedule the pharmaceutical composition of crystalline polymorph psilocybin in a drug product approved by the Food and Drug Administration as a Schedule IV controlled substance.

On HB 1099 — reschedule the pharmaceutical composition of crystalline polymorph psilocybin in a drug product approved by the Food and Drug Administration as a Schedule IV controlled substance.

Passed 21 Yea · 12 Nay · 2 Other ·

By party

Party YeaNayPresentNot Voting
Republican 171202
Democratic 3000
Unaffiliated 1000

How each member voted (35)